COMMUNIQUÉS West-GlobeNewswire

Grundy MD Consulting Physician Announces Expanded Focus on Services as a Missed Diagnosis Emergency Doctor & Malpractice Medical Legal Expert Witness for Head Injuries

01/04/2025 - 16:00

San Carlos, California , April 01, 2025 (GLOBE NEWSWIRE) -- Grundy MD Consulting Physician , led by board-certified emergency physician and medical-legal expert Dr. David Grundy, announced an expanded focus on services [...]

Thought Leadership & Innovation Foundation Awareness Month Published on American Hospital Association/Society for Health Care Strategy & Market Development Observance Calendar

01/04/2025 - 16:00

MCLEAN, Va., April 01, 2025 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and public health, proudly announces [...]

A family doctor for every Canadian: The CFPC calls on federal parties to act

01/04/2025 - 15:47

MISSISSAUGA, Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- The College of Family Physicians of Canada (CFPC) is calling on all federal political parties to commit to actions that protect and strengthen access to primary [...]

Un médecin de famille pour chaque Canadienne et Canadien : Le CMFC exhorte les partis fédéraux à agir

01/04/2025 - 15:47

MISSISSAUGA, Ontario, 01 avr. 2025 (GLOBE NEWSWIRE) -- Le Collège des médecins de famille du Canada (CMFC) exhorte les partis politiques fédéraux à prendre des mesures visant à protéger et renforcer l’accès aux soins [...]

Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks

01/04/2025 - 15:42

Groundbreaking Yeast Experiment from Dr. Nislow's lab on Last Night's SpaceX Fram2 Mission Advances Space-Based Biotechnology MELBOURNE, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. ( Ticker: [...]

Stride Autism Centers Named a Winner of the 2025 Top Workplaces USA Today During Autism Acceptance Month

01/04/2025 - 15:00

Stride Expands Across the Midwest, Celebrating its Tenth Center in Iowa and Sixth in Nebraska DES MOINES, Iowa, April 01, 2025 (GLOBE NEWSWIRE) -- Stride Autism Centers, a leading provider of center-based early [...]

Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart

01/04/2025 - 15:00

– FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation – – Expect to initiate both trials in Q2 2025 – SAN DIEGO, [...]

LogicMark Secures Approval to Deliver New Medical Alert with Cell Phone Tech to Veterans and Seniors Through U.S. General Services Administration

01/04/2025 - 15:00

The Freedom Alert Max brings life-saving fall detection, advanced geofencing capabilities, and patented 4G LTE mobile technology to vulnerable populations LOUISVILLE, Ky., April 01, 2025 (GLOBE NEWSWIRE) -- LogicMark, [...]

Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day

01/04/2025 - 15:00

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today [...]

GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

01/04/2025 - 15:00

The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data reviewed Interim results demonstrate GRI-0621 to be safe and well-tolerated [...]

ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®

01/04/2025 - 14:49

BURNABY, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Telix ARTMS, Inc. (ARTMS), a global leader in radioisotope production technologies, is pleased to announce that the drug master file (DMF) 1 for gallium-68 [...]

Updated biographies for board candidates at the upcoming Annual General Meeting

01/04/2025 - 14:34

1 April 2025 Announcement no. 8 Updated biographies for board candidates at the upcoming Annual General Meeting Copenhagen, Denmark, April 1, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an [...]

Cannabix Technologies to Attend U.S. National Drug and Alcohol Conference to Market Marijuana Breath Test

01/04/2025 - 14:30

VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing [...]

Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey

01/04/2025 - 14:30

Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures ROSELAND, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of [...]

REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

01/04/2025 - 14:30

Company Reaffirms Expected Timing of FDA Decision With Respect to 510(K) Clearance of LIBERTY® During the Current Second Quarter BRAINTREE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT [...]

Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial

01/04/2025 - 14:30

– Initial data readout on track for second half of 2025 HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a [...]

Clene to Present at the Jones Healthcare and Technology Innovation Conference

01/04/2025 - 14:30

SALT LAKE CITY, April 01, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical [...]

Aptose Common Shares to Delist from Nasdaq as of April 2, 2025

01/04/2025 - 14:30

SAN DIEGO and TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based [...]

Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025

01/04/2025 - 14:15

Solengepras showed evidence of potential benefit in functional and non-motor symptoms versus placebo as measured by MDS-UPRDS Parts I, II, NMSS, and ESS, consistent with its novel non-dopaminergic mechanism of action [...]